Solid Biosciences Inc. SLDB Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$174.33M-39.8% | -$124.7M-29.9% | -$96.02M-11.7% | -$85.98M-19.1% | ||
| $1.64M-33.4% | $2.46M-4.9% | $2.58M+7.2% | $2.41M-18.8% | ||
| $16.91M+60.8% | $10.52M+38.0% | $7.63M+1.2% | $7.54M-43.6% | ||
| -$156.29M-56.3% | -$100.01M-6.2% | -$94.18M+3.9% | -$97.98M-26.0% | ||
| $1.15M+76.3% | $654K-56.8% | $1.52M-49.8% | $3.02M+135% | ||
| —— | —— | $9.69M-83.6% | $59.16M— | ||
| $723K+52.9% | $473K— | —— | —— | ||
| $196.05M+60.1% | $122.44M— | —— | $74.83M-44.7% | ||
| -$20.3M— | —— | —— | $36.01M— | ||
| -$157.44M-56.4% | -$100.67M-5.2% | -$95.7M+5.2% | -$100.99M-27.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Solid Biosciences Inc. generate?
- Solid Biosciences Inc. (SLDB) generated -$171.7M in operating cash flow over the trailing twelve months.
- What is Solid Biosciences Inc.'s free cash flow?
- After $1.2M of capital expenditures, Solid Biosciences Inc.'s free cash flow was -$172.9M over the trailing twelve months, down 61.1% year over year.
- Where does Solid Biosciences Inc.'s cash flow data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
